© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
Howard Goldman, MD, discusses the possible effects of FDA reclassification of transvaginal mesh used for prolapse as well as the importance of adequate surgical training and patient selection.
Related Content:
News